MacroGenics
MGNX
#9419
Rank
โ‚น7.56 B
Marketcap
โ‚น119.61
Share price
-2.92%
Change (1 day)
-59.40%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.50. In 2024 the company made an earnings per share (EPS) of -โ‚น96.23 a decrease over its 2023 EPS that were of -โ‚น13.49.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.83%
2024-โ‚น96.23613.33%
2023-โ‚น13.49-92.31%
2022-โ‚น175.37-42.14%
2021-โ‚น303.0736.44%
2020-โ‚น222.13-21.84%
2019-โ‚น284.19-24.58%
2018-โ‚น376.82675.93%
2017-โ‚น48.56-68.05%
2016-โ‚น151.99168.25%
2015-โ‚น56.66-55%
2014-โ‚น125.913400%
2013-โ‚น3.60-108.68%
2012โ‚น41.4624.49%
2011โ‚น33.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น159.18 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.68-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น682.93-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น586.36-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,172-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,845-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น267.10-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA